Benefits/Risks of Syrup of Ipecac

1 April 1986

journal article
Published by American Academy of Pediatrics (AAP) in Pediatrics

Vol. 77 (4) , 551-552
https://doi.org/10.1542/peds.77.4.551

Abstract

The status of syrup of ipecac as a nonprescription drug has helped reduce the death rate in children, ages 1 to 5 years. The drug has proven safe and effective in children in the recommended doses. To deprive parents of ready access to ipecac syrup would result in increased disability and death from poisoning and more emergency department visits.

Keywords

CHILDREN
EMERGENCY DEPARTMENT
READY ACCESS
DEPARTMENT VISITS
NONPRESCRIPTION DRUG
SYRUP OF IPECAC
INCREASED DISABILITY
PROVEN SAFE

This publication has 0 references indexed in Scilit: